Amgen gets approval for two plants

09/7/2005 | Reuters

Amgen said the FDA approved new manufacturing plants, with Amgen's Enbrel to be produced at a plant in Rhode Island and Neupogen and Neulasta to be manufactured at a new plant in Puerto Rico. The company also said it was building a second facility at the Puerto Rico site for production of its anemia drug, Epogen.

View Full Article in:

Reuters

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Chief Executive Officer
Center for Improving Value in Healthcare
Denver, CO
Quality Program Manager II, State Programs
Tufts Health Plan
Watertown, MA
Associate Director, Promotion Integrity
Bristol-Myers Squibb
Plainsboro, NJ
Vice President, Medicare Advantage
BCBS-Louisiana
Baton Rouge, LA
Director, Global Integrity and Compliance, Pharmaceuticals
Alcon
Fort Worth, TX